US Drug Recall Register
Class II · Moderate risk Terminated Initiated Feb 12, 2020 (7 years ago)

Memantine Hydrochloride Extended Release Capsules, 21 mg, 30-count bottles, Rx Only…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Failed Dissolution Specifications: Low out of specification results observed in dissolution test at six-month long-term stability study.

What was recalled

Memantine Hydrochloride Extended Release Capsules, 21 mg, 30-count bottles, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202 United States. Manufactured by: Lupin Limited Pithampur (M.P.)-454 775, INDIA, NDC 68180-248-06

Recalling firm
Lupin Pharmaceuticals Inc.
NDC code
68180-248-06
Origin
MD, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0855-2020

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Chloride recalls

See all